Crispr Therapeutics shares owned by Nalls Sherbakoff Group
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Nalls Sherbakoff Group
from 13F filings
Historical chart of Nalls Sherbakoff Group investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Nalls Sherbakoff Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Nalls Sherbakoff Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $439 | 7 | 62.71 |
| 2023-09-30 | $318 | 7 | 45.43 |
| 2023-06-30 | $449 | 7 | 64.14 |
| 2023-03-31 | $309 | 7 | 44.29 |